Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Notes Payables (2021)

Akso Health (AHG) has disclosed Notes Payables for 1 consecutive years, with $10.0 million as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Notes Payables changed N/A year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Mar 2021, changed N/A, and an annual FY2021 reading of $10.0 million, changed N/A over the prior year.
  • Notes Payables was $10.0 million for Q1 2021 at Akso Health.
  • Across five years, Notes Payables topped out at $10.0 million in Q1 2021 and bottomed at $10.0 million in Q1 2021.